AbbVie (NYSE:ABBV) announced that results from part one of the Phase 2 portion of its Phase2/3 open-label study, TURQUOISE-I, in genotype 1 chronic hepatitis C patients with human immunodeficiency virus type 1 (HIV-1) co-infection were published online in The Journal of the American Medical Association (JAMA). Additional sub-analyses also will be presented in both oral and poster presentations on Feb. 26, at the Annual Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, Wash. On Monday shares of AbbVie Inc. (NYSE:ABBV) closed at $60.57. Company’s sales growth for last 5 years was 7.00% and EPS growth for next 5 years is recorded as 15.40%.
On Feb. 17, PDI, Inc. (NASDAQ:PDII) announced that it will release its financial and operating results for the fourth quarter and full year ended December 31, 2014 on Tuesday, March 3, 2015 after the market close. Management will host a conference call beginning at 4:30 pm Eastern time to discuss the results and answer questions. PDI, Inc. (NASDAQ:PDII) in last trading activity decreased -1.53% to close at $1.93. Company weekly performance is 4.89% while its quarterly performance stands at 9.66%. PDI, Inc. (NASDAQ:PDII) is -64.52% away from its 52 week high.
On Feb. 19, TearLab Corporation (NASDAQ:TEAR) expects to announce its Q4 and full year 2014 financial results after market closes on Thursday, March 12, 2015. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed.(NASDAQ:TEAR) advanced 6.35% to close at $2.68. Its volatility for the week is 8.17% while volatility for the month is 8.28%. TEAR’s sales growth for past 5 years was 96.40% and its EPS growth for past 5 years was 23.00%. TearLab Corporation (NASDAQ:TEAR) monthly performance is 25.82%.
Electro Scientific Industries Inc. (NASDAQ:ESIO) announced that Richard Wills has been appointed Chairman of the Board of Directors, replacing Jon Tompkins. Tompkins’ term as a director expires at the August 2015 annual meeting, and he is prohibited from being elected as a director for another term due to the age limitations in the Company’s Corporate Governance Guidelines. Tompkins has been appointed Vice Chairman of the Board for the duration of his term. On Monday shares of Electro Scientific Industries Inc. (NASDAQ:ESIO) closed at $6.32. Company’s sales growth for last 5 years was 2.90% and EPS growth for next 5 years is recorded as 20.00%.
On February 15, Cellcom Israel Ltd. (NYSE:CEL) announced it has entered a collective employment agreement with its employees’ representatives and the Histadrut (an Israeli union labor) for a term of 3 years (2015-2017). The agreement applies to the Company’s and 013 Netvision Ltd.’s (the Company’s indirect wholly owned subsidiary) employees, excluding certain managerial and specific positions. The agreement defines employment policy and terms in various aspects, including: minimum wages, annual salary increase, incentives, benefits and other one time or annual payments to the employees, as well as a welfare budget and procedures relating to manning a position, change of place of employment and dismissal, including management and employees’ representative respective authority with regards to each. On last trading day Cellcom Israel Ltd. (NYSE:CEL) advanced 2.31% to close at $6.19. Its volatility for the week is 1.96% while volatility for the month is 2.64%. CEL’s sales growth for past 5 years was -5.10% and its EPS growth for past 5 years was -22.20%. Cellcom Israel Ltd. (NYSE:CEL) monthly performance is 13.79%.